A Study of First Line Treatment With Avastin (Bevacizumab) in Combination With Carboplatin and Weekly Paclitaxel in Patients With Ovarian Cancer
Clinical trial NCT00937560 · COMPLETED
Trial details
- NCT number
- NCT00937560
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-06-25
- Primary completion
- 2012-07-31
- Enrollment
- 190
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.